[Federal Register: July 6, 2005 (Volume 70, Number 128)]
[Notices]
[Page 38936]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06jy05-111]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Joint Meeting of the National Vaccine Advisory Committee and the
Advisory Committee on Immunization Practices
AGENCY: Department of Health and Human Services, Office of the
Secretary.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As stipulated by the Federal Advisory Committee Act, the
Department of Health and Human Services (DHHS) is hereby giving notice
that the National Vaccine Advisory Committee (NVAC) and the Advisory
Committee on Immunization Practices (ACIP) will hold a joint meeting.
The meeting is open to the public.
DATES: The meeting will be held on July 19, 2005, from 9 a.m. to 4:30
p.m.
ADDRESSES: Department of Health and Human Services, 5635 Fishers Lane,
Terrace Level Conference Room, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst,
National Vaccine Program Office, Department of Health and Human
Services, Room 443-H, Hubert H. Humphrey Building, 200 Independence
Avenue, SW., Washington, DC 20201; telephone (202) 690-5566, or email
nvac@osophs.dhhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public
Health Service Act (42 U.S.C. Section 300aa-1), the Secretary of Health
and Human services was mandated to establish the National Vaccine
Program to achieve optimal prevention of human infectious diseases
through immunization and to achieve optimal prevention against adverse
reactions to vaccines. The NVAC was established to provide advice and
make recommendations to the Assistant Secretary for Health, as the
Director of the National Vaccine Program, on matters related to the
program's responsibilities.
The ACIP is charged with advising the Director, Centers for Disease
Control and Prevention (CDC), on the appropriate uses of immunizing
agents. In addition, under 42 U.S.C. Section 1396s, the ACIP is
mandated to establish and periodically review and, as appropriate,
revise the list of vaccines for administration to vaccine-eligible
children through the Vaccines for Children (VFC) program, along with
schedules regarding the appropriate periodicity, dosage, and
contraindications applicable to the vaccines.
This is a special meeting of the NVAC and the ACIP. Discussions
will surround the Department's draft Pandemic Influenza Preparedness
and Response Plan. A tentative agenda will be made available on or
about July 5, 2005 for review on the NVAC Web site: http://www.hhs.gov/nvpo/nvac
.
Public attendance at the meeting is limited to space available.
Individuals must provide a photo ID for entry into the building.
Individuals who plan to attend and need special assistance, such as
sign language interpretation or other reasonable accommodations, should
notify the designated contact person. Members of the public will have
the opportunity to provide comments at the meeting. Public comment will
be limited to five minutes per speaker. Any members of the public who
wish to have printed material distributed to NVAC and ACIP members
should submit materials to the Executive Secretary, NVAC, through the
contact person listed above prior to close of business July 15, 2005.
Preregistration is required for both public attendance and comment. Any
individual who wishes to attend the meeting and/or participate in the
public comment session should email nvac@osophs.dhhs.gov or call 202-
690-5566.
For this special meeting, remote participation will be made
available via a toll-free call-in phone number. This call-in number can
be obtained from the contact person identified above and will be
operator assisted to provide members of the public the opportunity to
provide comments to the Committees. Additionally, this meeting will be
Web cast at http://www.videocast.nih.gov. Online participants will be
able to e-mail comments to the Committees. However, Committee members
may not have the opportunity to read all written statements submitted
on the day of the meeting and prior to any votes that may be taken by
the Committees. It is recommended that written statements be provided
to the Executive Secretary, NVAC, through the contact person listed
above prior to close of business July 15, 2005.
Dated: June 29, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-13226 Filed 7-5-05; 8:45 am]
BILLING CODE 4150-44-P